Condition
Major Depressive Episode (MDE)
Total Trials
6
Recruiting
5
Active
5
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 6 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Recruiting5
Not Yet Recruiting1
Clinical Trials (6)
Showing 6 of 6 trials
NCT07723066Not Yet Recruiting
Biomarker Discovery for Suicide Precision Circuit Therapeutics
NCT07681492Not ApplicableRecruitingPrimary
Belief Update: The Effects of Depression and Antidepressants in Older People
NCT07621237Phase 2RecruitingPrimary
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
NCT06804525RecruitingPrimary
LHC-CIDI-5 in Hong Kong
NCT07258914Not ApplicableRecruiting
Feasibility and Efficacy of rTMS in Depression in Patients With Autism Spectrum Disorder (ASD)
NCT07031817Not ApplicableRecruiting
Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder
Showing all 6 trials